Cargando…
NT1721, a novel epidithiodiketopiperazine, exhibits potent in vitro and in vivo efficacy against acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive malignancy characterized by heterogeneous genetic and epigenetic changes in hematopoietic progenitors that lead to abnormal self-renewal and proliferation. Despite high initial remission rates, prognosis remains poor for most AML patients, especially for...
Autores principales: | Kowolik, Claudia M., Lin, Min, Xie, Jun, Overman, Larry E., Horne, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349906/ https://www.ncbi.nlm.nih.gov/pubmed/27863389 http://dx.doi.org/10.18632/oncotarget.13364 |
Ejemplares similares
-
Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma
por: Lin, Min, et al.
Publicado: (2021) -
Correction: Lin et al. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma. Cancers 2021, 13, 3367
por: Lin, Min, et al.
Publicado: (2021) -
Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
por: Kowolik, Claudia M., et al.
Publicado: (2019) -
Synthesis of Potent
Cytotoxic Epidithiodiketopiperazines
Designed
for Derivatization
por: Olsson, Chase R., et al.
Publicado: (2020) -
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer
por: Reece, Kelie M, et al.
Publicado: (2014)